ArticleChemMedChem2026
An Ugi-Joullié Platform for Medicinally Relevant 1,4-Dihydrobenzothiazines.
Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
A concise and modular synthetic platform for the rapid assembly of functionalized 1,4-dihydrobenzothiazines is reported through an Ugi-Joullié two-component reaction of a preformed benzothiazine-derived imine with diverse isocyanides. The methodology proceeds under mild, operationally simple conditions and exhibits broad isocyanide scope, accommodating aryl, benzylic, aliphatic, and heterocyclic substituents to furnish a 19-member library of benzothiazines in 51%-96% yields. The reaction demonstrates high functional-group tolerance and scalability to the millimole level, enabling efficient access to structurally diverse benzothiazine derivatives relevant for medicinal chemistry exploration. Single-crystal X-ray diffraction analyses revealed characteristic conformational features of the scaffold, including a twisted-boat geometry and a Z-oriented arrangement of the two NH groups. In addition, late-stage oxidation of the sulfur atom to the corresponding sulfone was readily achieved in high yield, highlighting the versatility of the scaffold for post-assembly diversification. Preliminary antimicrobial evaluation against a panel of Gram-positive and Gram-negative bacterial strains revealed strain-dependent antibacterial activity for selected derivatives, supporting the suitability of the benzothiazine framework for further medicinal chemistry optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.